✦ LIBER ✦

2044 Early and late toxicity of involved-field radiation therapy in conjunction with high-dose chemotherapy and stem cell rescue

✍ Scribed by L. Lubich; A. Mundt; G. Sibley; D. Hallahan; J. Nautiyal; R. Weichselbaum

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 89 KB
Volume: 32
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(95)97947-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tandem high-dose therapy in relapsed and

Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with131I-anti-CD20 antibody and stem cell rescue

✍ Karin Hohloch; Carsten Oliver Sahlmann; Vijai J. Lakhani; Gerald Wulf; Bertram G 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 233 KB

Early versus late intensification for pa

Early versus late intensification for patients with high-risk Hodgkin lymphoma—3 Cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation : Five-year results of a randomized trial on behalf of the GOELAMS group

✍ Nina Arakelyan; Christian Berthou; Bernard Desablens; Sophie de Guibert; Vincent 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views